Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is This Soaring Growth Stock a Buy?

TheMotleyFool

0 0

The stock market has recovered some of its losses over the past month, rising by nearly 11% in this period. Some companies are tagging along, including BioXcel Therapeutics (NASDAQ: BTAI), a small-cap biotech stock. BioXcel remains deep in the red for the year, but ongoing developments have helped fuel the company's recent run. And at a market capitalization of $430 million, its shares might be worth buying if there is more fuel left in its growth tank. Is this drugmaker worth investing in today?

BTAI data by YCharts.

Source Fool.com

Like: 0

BTAI

Share